155 results on '"Barkati, Sapha"'
Search Results
2. Treatment of Progressive Multifocal Leukoencephalopathy with IL-2 and Mirtazapine
3. Mpox in 2023: Current Epidemiology and Management
4. Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel Network: a cross-sectional study
5. Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study
6. Strongyloidiasis-related lung involvement: too much of a bad thing
7. Chikungunya infection in returned travellers: results from the geosentinel network, 2005–2020.
8. Clinical Characteristics and Outcomes Among Travelers With Severe Dengue
9. Implementing a Patient Portal for the Remote Follow-up of Self-isolating Patients with COVID-19 Through Patient and Stakeholder Engagement: A Mixed-Method Pilot Study (the Opal-COVID Study) (Preprint)
10. Cutaneous leishmaniasis in the 21st century: from the laboratory to the bedside
11. Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel Network: a cross-sectional study
12. Monkeypox in Montréal: Epidemiology, Phylogenomics, and Public Health Response to a Large North American Outbreak
13. Intravenous Liposomal Amphotericin B Efficacy and Safety for Cutaneous and Mucosal Leishmaniasis: A Systematic Review and Meta-analysis.
14. Dengue outbreak among travellers returning from Cuba—GeoSentinel surveillance network, January–September 2022
15. Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA–Vaccinated and Nonvaccinated Individuals in Quebec, Canada
16. Monkeypox outbreak 2022: “See one, do one, teach one” no longer the rule
17. Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
18. In-hospital outcomes of SARS-CoV-2-infected health care workers in the COVID-19 pandemic first wave, Quebec, Canada
19. Evaluation of Strongyloides Awareness and Knowledge among Canadian Physicians Caring for Patients At Risk for Severe Strongyloidiasis: A National Cross-sectional Survey
20. Strongyloides stercoralis prevalence in solid-organ and haematopoietic stem cell transplant candidates and recipients: a systematic review and meta-analysis protocol
21. Leishmaniose cutanee observee chez une jeune fille de 12 ans recemment immigree de Syrie
22. Cutaneous leishmaniasis in a 12-year-old Syrian immigrant
23. Protection against Omicron BA.2 reinfection conferred by primary Omicron or pre-Omicron infection with and without mRNA vaccination
24. Protection against Omicron re-infection conferred by prior heterologous SARS-CoV-2 infection, with and without mRNA vaccination
25. Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada
26. Outcomes of hospitalized COVID-19 patients in Canada: impact of ethnicity, migration status and country of birth
27. Cutaneous leishmaniasis in travellers and migrants: a 10-year case series in a Canadian reference centre for tropical diseases
28. Dengue outbreak amongst travellers returning from Cuba—GeoSentinel surveillance network, January–September 2022.
29. Two-dose SARS-CoV-2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies from British Columbia and Quebec, Canada
30. Strongyloidiasis in immunocompromised migrants to non-endemic countries in the era of COVID-19: what is the role for presumptive ivermectin?
31. Single-Dose Messenger RNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 in Healthcare Workers Extending 16 Weeks Postvaccination: A Test-Negative Design From Québec, Canada
32. Single-dose mRNA vaccine effectiveness against SARS-CoV-2 in healthcare workers extending 16 weeks post-vaccination: a test-negative design from Quebec, Canada
33. Single-Dose Messenger RNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 in Healthcare Workers Extending 16 Weeks Postvaccination: A Test-Negative Design From Québec, Canada.
34. Cutaneous leishmaniasis and the vicious cycle of neglect
35. Intravenous liposomal amphotericin B efficacy and safety for cutaneous and mucosal leishmaniasis: a systematic review and meta-analysis protocol
36. Cutaneous and mucocutaneous leishmaniasis in travellers and migrants: a 20-year GeoSentinel Surveillance Network analysis
37. Strongyloidiasis in immunocompromised migrants to non-endemic countries in the era of COVID-19: what is the role for presumptive ivermectin?
38. Shigella spp. with reduced azithromycin susceptibility, Quebec, Canada, 2012-2013
39. COVID-19: Exposing and addressing health disparities among ethnic minorities and migrants
40. Isolated muscular cystic echinococcosis mimicking neoplasia
41. Renal actinomycosis presenting as uro-cutaneous fistula
42. A recurrent hydatid cyst of the thigh diagnosed 13 years after initial presentation
43. Decision Tool for Herpes B Virus Antiviral Prophylaxis after Macaque-Related Injuries in Research Laboratory Workers
44. A 9-Year-Old Female With a Cough and Cavitary Lung Lesion
45. Malaria after international travel: a GeoSentinel analysis, 2003-2016
46. First Human Case of Metacestode Infection Caused byVersteriasp. in a Kidney Transplant Recipient
47. Intradermal pre-exposure rabies vaccination in a Canadian travel clinic: 6-year retrospective observational study
48. A secondary syphilis rash with scaly target lesions
49. Practices of Lyme disease diagnosis and treatment by general practitioners in Quebec, 2008–2015
50. Multifocal ulceronecrotic skin lesions—A stigmatizing case
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.